Drug Delivery

NASAL DELIVERY – A Promising Route of Drug Delivery to the Brain: Scientific Considerations

Vinayak Pathak, MPharm, MBA, indicates after reviewing clinical experiments published in this area, it is evident that formulation design, altering the physico-chemical properties of the drug, addition of absorption enhancers, and mucoadhesive polymers did result in higher bioavailability of drugs in animal models via the nasal route when compared to parenteral administration of the same drug.

EXCLUSIVE ONLINE CONTENT

7/8/2018

Pfenex Receives Milestone From Merck

Pfenex Inc. recently announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease. 

7/8/2018

Immatics Enters Strategic Partnership With Genmab

Immatics Biotechnologies GmbH recently announced it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications.

7/8/2018

Gerresheimer Acquires Sensile Medical

With the acquisition of Sensile Medical AG, Switzerland  under a recent share purchase agreement, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.